Abstract:Background: The EPOCH regimen, consisting of vincristine sulfate, doxorubicin hydrochloride, and etoposide phosphate, is typically administered by continuous infusion over four days to oncology inpatients. If the EPOCH regimen was available to be administered through portable elastomeric pumps, chemotherapy could be transitioned to an outpatient setting, reducing inpatient bed days and overall healthcare costs. However, a lack of stability data for the admixtures in the elastomeric infusion devices currently prevents the transition of the regime to an outpatient setting. The purpose of this study is to determine the physical and chemical stability of the admixture in polyisoprene elastomeric pumps under different storage conditions to support the transition of the EPOCH regime to an outpatient setting. Methods: The physico-chemical stability of three admixtures at a range of clinically relevant concentrations compounded in polyisoprene elastomeric infusors was determined when refrigerated at 2-6℃ over a 14-day period followed by 35℃ up to 7 days in the dark, and under standardized fluorescent light to simulate scenarios in clinical practice. Results: All tested admixtures were compatible and the drugs were stable in the elastomeric infusors for up to 14 days when stored at 2-6℃ followed by 7 days at 35℃ in the dark, with nominal losses of <5%. The major degradant of etoposide phosphate was its active form etoposide. There was no degradation (<1% loss) found when the admixture was exposed to a standardized fluorescent light dose of 80 klux-h (25℃) for 10 h. The temperature and light conditions the infusors were exposed to during the stability study were more severe than the conditions determine during clinical administration. Conclusion: The extended stability of the three infusional admixtures compounded in elastomeric infusion pumps demonstrated herein permits advance preparation and storage of these drugs, reducing pharmacy compounding resources. The demonstrated stability at 35℃ and under light exposure, conditions more severe than those experienced during clinical practice, support continuous infusions for up to seven days from the elastomeric infusors without a loss of potency. The proven stability of the EPOCH regimens in the tested elastomeric infusion device supports the transition of treatment to an outpatient setting which will reduce inpatient bed days and overall healthcare costs.

Pressure generated on a simulated mandibular oral analog by impression materials in custom trays of different design.

Home case management of malaria: an ethnographic study of lay people's classification of drugs in Suneka Division, Kenya

Stability of vincristine sulfate, doxorubicin hydrochloride and etoposide phosphate admixtures in polyisoprene elastomeric pump supporting transition of the EPOCH regimen to outpatient care

Stability of intravenous admixtures of doxorubicin and vincristine

In vitro compatibility of admixture solutions of 5-fluorouracil and khapzory (disodium levofolinate) in a single infusion bag

Preparation of etoposide liposomes for enhancing antitumor efficacy on small cell lung cancer and reducing hematotoxicity of drugs

Long term stability of an admixture of alizapride and ondansetron in 0.9% sodium chloride solution polyolefin bags stored at 5±3°C

[Effects of organic manures on CO2 and CH4 fluxes of farmland].

Development of etoposide-loaded bovine serum albumin nanosuspensions for parenteral delivery

[Osseous metastases of chemodectomas of the carotid body].

Establishment of drug delivery systems of vinorelbine-loaded erythrocytes and the in-vitro evaluation

Studies on the optimization of decontamination protocol for surfaces contaminated with cytotoxic drugs in PIVAS

Drug compatibility with various closed intravenous infusion containers

A Standardized Wedelia chinensis Extract Overcomes the Feedback Activation of HER2/3 Signaling upon Androgen-Ablation in Prostate Cancer

Stability of diluted adenosine solutions in polyvinyl chloride infusion bags

ISCHEMIC INDEX AND NEOVASCULARIZATION IN CENTRAL RETINAL VEIN OCCLUSION

Which Polymer is More Suitable for Etoposide: A Comparison Between Two Kinds of Drug Loaded Polymeric Micelles in Vitro and in Vivo?

[Clinical Study on High-Dose Etoposide with Granulocyte Colony-Stimulating Factor for Mobilization of Autologous Peripheral Blood Stem Cells in Patients with Hematologic Malignancies].

[Efficacy and Tolerability of the Combination of Oxaliplatin, Ifosfamide, and Epirubicin in Treatment of Recurrent or Platinum-Resistant Ovarian Epithelial Cancer Patients].

Control by Iron of Chlorophyll Formation and Growth in Euglena gracilis.

Stability of I.v. Admixture Containing Metoclopramide, Diphenhydramine Hydrochloride, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Injection.